The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension

We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral silde...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pediatric and neonatal individualized medicine 2015-04, Vol.4 (1), p.e040108-e040108
Main Authors: Galina A. Alyamovskaya, Elena S. Keshishian, Elena G. Verchenko, Vera V. Bereznitskaya
Format: Article
Language:English
Subjects:
bronchopulmonary dysplasia
premature infants
pulmonary arterial hypertension
sildenafil
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page e040108
container_issue 1
container_start_page e040108
container_title Journal of pediatric and neonatal individualized medicine
container_volume 4
creator Galina A. Alyamovskaya
Elena S. Keshishian
Elena G. Verchenko
Vera V. Bereznitskaya
description We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral sildenafil treatment was continued for 11 months. Oxygen supplement was suspended after 4 months and captopril administration was finished after 7 months of sildenafil treatment. There were no adverse effects during the treatment period. The respiratory failure decreased significantly and pulmonary arterial pressure became normal after 7 months of sildenafil treatment.
doi_str_mv 10.7363/040108
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6ae7b3def8ef4dd1a1cad881dd34fa20</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6ae7b3def8ef4dd1a1cad881dd34fa20</doaj_id><sourcerecordid>oai_doaj_org_article_6ae7b3def8ef4dd1a1cad881dd34fa20</sourcerecordid><originalsourceid>FETCH-LOGICAL-d151t-f8107eb5c3e3be394a209fa9f4d523fbb42ffd57feb01b92cc3967c12e863e6b3</originalsourceid><addsrcrecordid>eNotjltLwzAYhoMgOOb8DfkD1RzaNL2U4WEw2M28Ll-SLy4jTUuaKfv3FvXqheflPRDywNljK5V8YjXjTN-QlRCaV0x14o5s5vnMGOM1V0rLFcHjCamNIQULkVqYkY6eziE6TOBDpOCGxZxLhhLGREOiQL8wX-mUcYByybgwD6nQ71BOdLrEYUyw-KfrhLlgmpfYPbn1EGfc_OuafLy-HLfv1f7wtts-7yvHG14qrzlr0TRWojQouxoE6zx0vnaNkN6YWnjvmtajYdx0wlrZqdZygVpJVEauye6v141w7qcchuVJP0Lof8GYP3vIJdiIvQJsjXToNS71jgO34LTmzsnaL7vyB78pZUs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension</title><source>IngentaConnect Journals</source><creator>Galina A. Alyamovskaya ; Elena S. Keshishian ; Elena G. Verchenko ; Vera V. Bereznitskaya</creator><creatorcontrib>Galina A. Alyamovskaya ; Elena S. Keshishian ; Elena G. Verchenko ; Vera V. Bereznitskaya</creatorcontrib><description>We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral sildenafil treatment was continued for 11 months. Oxygen supplement was suspended after 4 months and captopril administration was finished after 7 months of sildenafil treatment. There were no adverse effects during the treatment period. The respiratory failure decreased significantly and pulmonary arterial pressure became normal after 7 months of sildenafil treatment.</description><identifier>EISSN: 2281-0692</identifier><identifier>DOI: 10.7363/040108</identifier><language>eng</language><publisher>Hygeia Press di Corridori Marinella</publisher><subject>bronchopulmonary dysplasia ; premature infants ; pulmonary arterial hypertension ; sildenafil</subject><ispartof>Journal of pediatric and neonatal individualized medicine, 2015-04, Vol.4 (1), p.e040108-e040108</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Galina A. Alyamovskaya</creatorcontrib><creatorcontrib>Elena S. Keshishian</creatorcontrib><creatorcontrib>Elena G. Verchenko</creatorcontrib><creatorcontrib>Vera V. Bereznitskaya</creatorcontrib><title>The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension</title><title>Journal of pediatric and neonatal individualized medicine</title><description>We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral sildenafil treatment was continued for 11 months. Oxygen supplement was suspended after 4 months and captopril administration was finished after 7 months of sildenafil treatment. There were no adverse effects during the treatment period. The respiratory failure decreased significantly and pulmonary arterial pressure became normal after 7 months of sildenafil treatment.</description><subject>bronchopulmonary dysplasia</subject><subject>premature infants</subject><subject>pulmonary arterial hypertension</subject><subject>sildenafil</subject><issn>2281-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNotjltLwzAYhoMgOOb8DfkD1RzaNL2U4WEw2M28Ll-SLy4jTUuaKfv3FvXqheflPRDywNljK5V8YjXjTN-QlRCaV0x14o5s5vnMGOM1V0rLFcHjCamNIQULkVqYkY6eziE6TOBDpOCGxZxLhhLGREOiQL8wX-mUcYByybgwD6nQ71BOdLrEYUyw-KfrhLlgmpfYPbn1EGfc_OuafLy-HLfv1f7wtts-7yvHG14qrzlr0TRWojQouxoE6zx0vnaNkN6YWnjvmtajYdx0wlrZqdZygVpJVEauye6v141w7qcchuVJP0Lof8GYP3vIJdiIvQJsjXToNS71jgO34LTmzsnaL7vyB78pZUs</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Galina A. Alyamovskaya</creator><creator>Elena S. Keshishian</creator><creator>Elena G. Verchenko</creator><creator>Vera V. Bereznitskaya</creator><general>Hygeia Press di Corridori Marinella</general><scope>DOA</scope></search><sort><creationdate>20150401</creationdate><title>The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension</title><author>Galina A. Alyamovskaya ; Elena S. Keshishian ; Elena G. Verchenko ; Vera V. Bereznitskaya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d151t-f8107eb5c3e3be394a209fa9f4d523fbb42ffd57feb01b92cc3967c12e863e6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>bronchopulmonary dysplasia</topic><topic>premature infants</topic><topic>pulmonary arterial hypertension</topic><topic>sildenafil</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galina A. Alyamovskaya</creatorcontrib><creatorcontrib>Elena S. Keshishian</creatorcontrib><creatorcontrib>Elena G. Verchenko</creatorcontrib><creatorcontrib>Vera V. Bereznitskaya</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of pediatric and neonatal individualized medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galina A. Alyamovskaya</au><au>Elena S. Keshishian</au><au>Elena G. Verchenko</au><au>Vera V. Bereznitskaya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension</atitle><jtitle>Journal of pediatric and neonatal individualized medicine</jtitle><date>2015-04-01</date><risdate>2015</risdate><volume>4</volume><issue>1</issue><spage>e040108</spage><epage>e040108</epage><pages>e040108-e040108</pages><eissn>2281-0692</eissn><abstract>We report the use of oral sildenafil in a 7-month-old preterm newborn with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to captopril and inhaled budesonide, and need of consistent oxygenation. Sildenafil was prepared as a powder for oral administration. Oral sildenafil treatment was continued for 11 months. Oxygen supplement was suspended after 4 months and captopril administration was finished after 7 months of sildenafil treatment. There were no adverse effects during the treatment period. The respiratory failure decreased significantly and pulmonary arterial pressure became normal after 7 months of sildenafil treatment.</abstract><pub>Hygeia Press di Corridori Marinella</pub><doi>10.7363/040108</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2281-0692
ispartof Journal of pediatric and neonatal individualized medicine, 2015-04, Vol.4 (1), p.e040108-e040108
issn 2281-0692
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6ae7b3def8ef4dd1a1cad881dd34fa20
source IngentaConnect Journals
subjects bronchopulmonary dysplasia
premature infants
pulmonary arterial hypertension
sildenafil
title The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A23%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20case%20of%20sildenafil%20administration%20in%20a%20very%20premature%20infant%20with%20pulmonary%20hypertension&rft.jtitle=Journal%20of%20pediatric%20and%20neonatal%20individualized%20medicine&rft.au=Galina%20A.%20Alyamovskaya&rft.date=2015-04-01&rft.volume=4&rft.issue=1&rft.spage=e040108&rft.epage=e040108&rft.pages=e040108-e040108&rft.eissn=2281-0692&rft_id=info:doi/10.7363/040108&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_6ae7b3def8ef4dd1a1cad881dd34fa20%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d151t-f8107eb5c3e3be394a209fa9f4d523fbb42ffd57feb01b92cc3967c12e863e6b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true